​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.59% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics-5.18%94.81%
SectorHealthcare Stocks 479.67%11.03%-390.70%
IndustryBiotech Stocks 295.80%10.97%-206.77%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-2,350---1---
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.33M2.59%-
Vanguard US Total Market Shares ETF1.23M2.53%-
iShares Russell 2000 ETF1.04M2.04%-19.84K
Vanguard Institutional Extnd Mkt Idx Tr805.68K1.57%127.58K
Simplify Propel Opportunities ETF558.58K1.09%-
Kennedy Micro Cap529.32K1.03%37.89K
iShares Russell 2000 Growth ETF358.01K0.70%-
Fidelity Extended Market Index267.50K0.52%42.26K
abrdn Life Sciences Investors224.36K0.46%-
Vanguard Russell 2000 ETF222.29K0.43%222.29K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 14, 2025Crombez Eric-Sell$32.68K
Aug 15, 2025Vazzano Joseph Walter Chief Financial OfficerSell$110.36K
Jul 22, 2025Vazzano Joseph Walter Chief Financial OfficerSell$9.97K
Jul 09, 2025Silverstein Christine Berni-Sell$76.67K
Jul 09, 2025Seshadri Vishwas Chief Executive OfficerSell$406.50K

Insider Transactions Trends

DateBuySell
2025 Q3-10
2025 Q2-5
2025 Q1-3
2024 Q4--
2024 Q3--

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 295.80%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.59% of its total shares outstanding invested in 1.33M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools